Print
contact ussite map
Juvaris Beotherapeutics, Inc.

Management Team

Grant E. Pickering
President and Chief Executive Officer

In the first quarter of 2008, Mr. Pickering was appointed President and CEO, and also elected to the Company's Board of Directors. Prior to joining Juvaris, Mr. Pickering founded Pharmada, Inc. with the Fred Hutchinson Cancer Research Center and served as its President and Chief Executive Officer. This biopharmaceutical company focused on the development of small-molecule therapeutics for the treatment of cancer. From 2000 through 2005, Mr. Pickering was employed by Dendreon Corporation where he served as a Corporate Officer and as its Senior Vice President of Operations. During his tenure at Dendreon, he led clinical development, manufacturing, sales, marketing, business development, project management, while playing a major role in fundraising activities, including the company's initial public offering. Before Dendreon, he held senior management roles in marketing and business development with Algos Pharmaceutical Corporation prior to participating in its sale to Endo Pharmaceuticals. Prior to Algos, Mr. Pickering was in sales- and marketing-related roles with Glaxo and Johnson & Johnson's Ortho Pharmaceutical Corporation. Mr. Pickering earned his B.S. degree in marketing from The Pennsylvania State University and was Beta Gamma Sigma at Georgetown University's MBA program graduating magna cum laude.

^ back to top

Kimberlee Gonzaga, CPA
Chief Financial Officer

Ms. Gonzaga brings over 15 years of financial management experience in public accounting, the medical device industry and most recently in biotech, across both established and early-stage companies. Prior to joining Juvaris, she was with Thoratec Corporation where she held several financial management positions before being named Sr. Strategic Finance Manager. Ms. Gonzaga was responsible for all aspects of consolidated budgeting and planning for multiple divisions, quarterly investor relations for all financial press releases including analyst's reviews, and worked extensively with business development in all aspects of mergers and acquisitions and other material agreements. Prior to Thoratec Corporation, Ms. Gonzaga held progressive positions with Stryker Corporation, Smith & Nephew, Inc. and with Oratec Interventions, Inc. At Oratec, she was a key contributor in the company's initial public offering, the acquisition of a small company and later the company's acquisition by Smith & Nephew. A licensed Certified Public Accountant, Ms. Gonzaga earned her B.S. degree, with a double major in accounting and economics/finance from Notre Dame de Namur University.

^ back to top

© 2014 Juvaris BioTherapeutics.